Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Immunoglobulin Light-chain Amyloidosis × Drug Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 70 Breast Neoplasms 30 Lung Neoplasms 22 Colorectal Neoplasms 22 Rectal Neoplasms 21 Neoplasms 18 Esophageal Squamous Cell Carcinoma 18 Neoplasm Metastasis 15 Head and Neck Neoplasms 15 Esophageal Neoplasms 15 Stomach Neoplasms 13 Squamous Cell Carcinoma of Head and Neck 12 Small Cell Lung Carcinoma 12 Pancreatic Neoplasms 12 Triple Negative Breast Neoplasms 11 Ovarian Neoplasms 11 Carcinoma, Squamous Cell 10 Nasopharyngeal Carcinoma 9 Colonic Neoplasms 8 Recurrence 7 Prostatic Neoplasms 7 Lymphoma, Large B-Cell, Diffuse 7 Lymphoma 7 Leukemia, Myeloid, Acute 7 Sarcoma 6 Melanoma 6 Lymphoma, Non-Hodgkin 6 Uterine Cervical Neoplasms 5 Fallopian Tube Neoplasms 5 Cholangiocarcinoma 5

Interventions

Dexamethasone 21 Melphalan 17 Cyclophosphamide 12 Bortezomib 10 Filgrastim 9 Peripheral Blood Stem Cell Transplantation 7 Calcium Dobesilate 7 daratumumab 6 Lenalidomide 6 pomalidomide 4 dexamethasone acetate 3 birtamimab 3 Thalidomide 3 Radiotherapy 3 Interferon-alpha 3 Granulocyte Colony-Stimulating Factor 3 sargramostim 2 dexamethasone 21-phosphate 2 belantamab mafodotin 2 Focal Adhesion Protein-Tyrosine Kinases 2 Etoposide 2 Doxycycline 2 Busulfan 2 siltuximab 1 pegfilgrastim 1 ixazomib 1 isatuximab 1 fludarabine phosphate 1 elotuzumab 1 auricularum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01531751 2018-03-21

DIACAL

Fondazione IRCCS Policlinico San Matteo di Pavia

Phase 2 Withdrawn

Immunoglobulin Light-chain Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡